Cheng Lei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Cheng Lei has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Hong Luo
Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital, Central South University, China
5 shared publications Binyi Yang
Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital, Central South University , Changsha, Hunan 410011, China
2 shared publicationsDanhui Yang
Department of Pulmonary and Critical Care Medicine, the Second Xiangya Hospital, Central South University
2 shared publicationsLin Wang
Department of Pulmonary and Critical Care Medicine, the Second Xiangya Hospital, Central South University
2 shared publicationsTing Guo
Department of Pulmonary and Critical Care Medicine, the Second Xiangya Hospital, Central South University
2 shared publicationsYingjie Xu
Department of Pulmonary and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, China
2 shared publications
Latest Publications
- Open Access
- 9 June 2026
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1) , 2681234
Differentiating benign from malignant pulmonary nodules in the context of bronchiectasis: a retrospective study
Pulmonary nodules are common on chest CT in bronchiectasis (BE) patients. This study identifies risk factors for nodule malignancy in BE patients with pulmonary nodules. We screened BE patients who underwent chest CT at Second Xiangya Hospital from Jan 1, 2019 to Mar 31, 2025. Only patients with pulmonary nodules and pathological results were enrolled. Univariate and multivariate logistic regression were performed to identify independent predictors of malignancy. , Of 143 patients, 28 had benign nodules and 115 had malignant nodules. Malignant nodules were more often pure ground‑glass/ground glass with a solid component nodule type (73.9% vs 28.6%, p<0.001) and upper lobe located (54.8% vs 32.1%, p=0.032). Benign nodules most commonly showed inflammation (60.7%), while malignant nodules were predominantly invasive adenocarcinoma (86.9%). Pure ground‑glass/ground glass with a solid component nodule type was the only independent predictor of malignancy (adjusted OR 8.53, 95% CI 3.14–25.81). Upper lobe location did not remain significant after adjustment. Reiff score and same‑lobe BE‑nodule coexistence were not significantly associated. Among BE patients with pulmonary nodules, pure ground‑glass/ground glass with a solid component nodule type independently predicts malignancy. This may aid clinical decision‑making.
- 9 June 2026
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1) , 2681234
Open AccessDifferentiating benign from malignant pulmonary nodules in the context of bronchiectasis: a retrospective study
Pulmonary nodules are common on chest CT in bronchiectasis (BE) patients. This study identifies risk factors for nodule malignancy in BE patients with pulmonary nodules. We screened BE patients who underwent chest CT at Second Xiangya Hospital from Jan 1, 2019 to Mar 31, 2025. Only patients with pulmonary nodules and pathological results were enrolled. Univariate and multivariate logistic regression were performed to identify independent predictors of malignancy. , Of 143 patients, 28 had benign nodules and 115 had malignant nodules. Malignant nodules were more often pure ground‑glass/ground glass with a solid component nodule type (73.9% vs 28.6%, p<0.001) and upper lobe located (54.8% vs 32.1%, p=0.032). Benign nodules most commonly showed inflammation (60.7%), while malignant nodules were predominantly invasive adenocarcinoma (86.9%). Pure ground‑glass/ground glass with a solid component nodule type was the only independent predictor of malignancy (adjusted OR 8.53, 95% CI 3.14–25.81). Upper lobe location did not remain significant after adjustment. Reiff score and same‑lobe BE‑nodule coexistence were not significantly associated. Among BE patients with pulmonary nodules, pure ground‑glass/ground glass with a solid component nodule type independently predicts malignancy. This may aid clinical decision‑making.
- Open Access
- 27 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-17
Deep longitudinal lower respiratory tract microbiome profiling reveals genome-resolved functional and evolutionary dynamics in critical illness
The lower respiratory tract (LRT) microbiome impacts human health, especially among critically ill patients. However, comprehensive characterizations of the LRT microbiome remain challenging due to low microbial mass and host contamination. We develop a chelex100-based low-biomass microbial-enrichment method (CMEM) that enables deep metagenomic profiling of LRT samples to recover near-complete microbial genomes. We apply the method to 453 longitudinal LRT samples from 157 intensive care unit (ICU) patients in three geographically distant hospitals. We recover 120 high-quality metagenome-assembled genomes (MAGs) and associated plasmids without culturing. We detect divergent longitudinal microbiome dynamics and hospital-specific dominant opportunistic pathogens and resistomes in pneumonia patients. Diagnosed pneumonia and the ICU stay duration were associated with the abundance of specific antibiotic-resistance genes (ARGs). Moreover, CMEM can serve as a robust tool for genome-resolved analyses. MAG-based analyses reveal strain-specific resistome and virulome among opportunistic pathogen strains. Evolutionary analyses discover increased mobilome in prevailing opportunistic pathogens, highly conserved plasmids, and new recombination hotspots associated with conjugative elements and prophages. Integrative analysis with epidemiological data reveals frequent putative inter-patient strain transmissions in ICUs. In summary, we present a genome-resolved functional, transmission, and evolutionary landscape of the LRT microbiota in critically ill patients.
- 27 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-17
Open AccessDeep longitudinal lower respiratory tract microbiome profiling reveals genome-resolved functional and evolutionary dynamics in critical illness
The lower respiratory tract (LRT) microbiome impacts human health, especially among critically ill patients. However, comprehensive characterizations of the LRT microbiome remain challenging due to low microbial mass and host contamination. We develop a chelex100-based low-biomass microbial-enrichment method (CMEM) that enables deep metagenomic profiling of LRT samples to recover near-complete microbial genomes. We apply the method to 453 longitudinal LRT samples from 157 intensive care unit (ICU) patients in three geographically distant hospitals. We recover 120 high-quality metagenome-assembled genomes (MAGs) and associated plasmids without culturing. We detect divergent longitudinal microbiome dynamics and hospital-specific dominant opportunistic pathogens and resistomes in pneumonia patients. Diagnosed pneumonia and the ICU stay duration were associated with the abundance of specific antibiotic-resistance genes (ARGs). Moreover, CMEM can serve as a robust tool for genome-resolved analyses. MAG-based analyses reveal strain-specific resistome and virulome among opportunistic pathogen strains. Evolutionary analyses discover increased mobilome in prevailing opportunistic pathogens, highly conserved plasmids, and new recombination hotspots associated with conjugative elements and prophages. Integrative analysis with epidemiological data reveals frequent putative inter-patient strain transmissions in ICUs. In summary, we present a genome-resolved functional, transmission, and evolutionary landscape of the LRT microbiota in critically ill patients.
- 13 September 2024
- Published by Elsevier in Laboratory Investigation
- Vol. 37 (10) , 100597
RNA Sequencing May Call CEP170::RAD51B Fusion Because of Alignment Artifacts
- 13 September 2024
- Published by Elsevier in Laboratory Investigation
- Vol. 37 (10) , 100597
RNA Sequencing May Call CEP170::RAD51B Fusion Because of Alignment Artifacts
- Open Access
- 19 April 2023
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 116 (8) , 691-693
A novel COL3A1 variant associated with vascular Ehlers–Danlos syndrome in a patient presents as recurrent pneumothorax with cavities
Ting Guo, Ying Liu, Siqi Lvqiu, Cheng Lei, Wen Long He, Yi Jiang, Danhui Yang, Rongchun Wang, Binyi Yang, Chenyang Lu, Yingjie Xu, Shuizi Ding, Lin Wang, Hong L
- 19 April 2023
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 116 (8) , 691-693
Open AccessA novel COL3A1 variant associated with vascular Ehlers–Danlos syndrome in a patient presents as recurrent pneumothorax with cavities
Ting Guo, Ying Liu, Siqi Lvqiu, Cheng Lei, Wen Long He, Yi Jiang, Danhui Yang, Rongchun Wang, Binyi Yang, Chenyang Lu, Yingjie Xu, Shuizi Ding, Lin Wang, Hong L
- 1 March 2023
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 207 (5) , e29-e30
Pulmonary Alveolar Microlithiasis in a Patient with Ellis–van Creveld Syndrome
- 1 March 2023
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 207 (5) , e29-e30
Pulmonary Alveolar Microlithiasis in a Patient with Ellis–van Creveld Syndrome
- Open Access
- 22 February 2018
- Published by Springer Nature in Molecular Cancer
- Vol. 17 (1) , 1-14
Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer
MicroRNAs (miRNAs) are endogenous non-coding RNAs that contain approximately 22 nucleotides. They serve as key regulators in various biological processes and their dysregulation is implicated in many diseases including cancer and autoimmune disorders. It has been well established that the maturation of miRNAs occurs in the cytoplasm and miRNAs exert post-transcriptional gene silencing (PTGS) via RNA-induced silencing complex (RISC) pathway in the cytoplasm. However, numerous studies reaffirm the existence of mature miRNA in the nucleus, and nucleus-cytoplasm transport mechanism has also been illustrated. Moreover, active regulatory functions of nuclear miRNAs were found including PTGS, transcriptional gene silencing (TGS), and transcriptional gene activation (TGA), in which miRNAs bind nascent RNA transcripts, gene promoter regions or enhancer regions and exert further effects via epigenetic pathways. Based on existing interaction rules, some miRNA binding sites prediction software tools are developed, which are evaluated in this article. In addition, we attempt to explore and review the nuclear functions of miRNA in immunity, tumorigenesis and invasiveness of tumor. As a non-canonical aspect of miRNA action, nuclear miRNAs supplement miRNA regulatory networks and could be applied in miRNA based therapies.
- 22 February 2018
- Published by Springer Nature in Molecular Cancer
- Vol. 17 (1) , 1-14
Open AccessNuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer
MicroRNAs (miRNAs) are endogenous non-coding RNAs that contain approximately 22 nucleotides. They serve as key regulators in various biological processes and their dysregulation is implicated in many diseases including cancer and autoimmune disorders. It has been well established that the maturation of miRNAs occurs in the cytoplasm and miRNAs exert post-transcriptional gene silencing (PTGS) via RNA-induced silencing complex (RISC) pathway in the cytoplasm. However, numerous studies reaffirm the existence of mature miRNA in the nucleus, and nucleus-cytoplasm transport mechanism has also been illustrated. Moreover, active regulatory functions of nuclear miRNAs were found including PTGS, transcriptional gene silencing (TGS), and transcriptional gene activation (TGA), in which miRNAs bind nascent RNA transcripts, gene promoter regions or enhancer regions and exert further effects via epigenetic pathways. Based on existing interaction rules, some miRNA binding sites prediction software tools are developed, which are evaluated in this article. In addition, we attempt to explore and review the nuclear functions of miRNA in immunity, tumorigenesis and invasiveness of tumor. As a non-canonical aspect of miRNA action, nuclear miRNAs supplement miRNA regulatory networks and could be applied in miRNA based therapies.